Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Volavka

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Psychiatry|August 10, 2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST)Jan Volavka, Pal Czobor, Eske M Derks, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia TrialPál Czobor, Jan Volavka, Eske M Derks, et al.
The Journal of Clinical Psychiatry|January 20, 2006
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studiesJan Volavka, Pal Czobor, Leslie Citrome, et al.
Psychopharmacology|August 26, 2006
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medicationGwyneth Zai, Daniel J Müller, Jan Volavka, et al.
Human Psychopharmacology|August 19, 2007
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysisVincenzo De Luca, Daniel J Müller, Rudi Hwang, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch studyJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
Psychiatric Services (Washington, D.C.)|July 10, 2003
Characteristics of assaultive behavior among psychiatric inpatientsKaren A Nolan, Pál Czobor, Biman B Roy, et al.
The Journal of Clinical Psychiatry|January 28, 2004
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka, Pal Czobor, Thomas B Cooper, et al.
Journal of Psychiatric Research|October 27, 2004
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderKaren A Nolan, Jan Volavka, Pal Czobor, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
Antipsychotic-induced weight gain and therapeutic response: a differential associationPál Czobor, Jan Volavka, Brian Sheitman, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|August 10, 2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST)Jan Volavka, Pal Czobor, Eske M Derks, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia TrialPál Czobor, Jan Volavka, Eske M Derks, et al.
The Journal of Clinical Psychiatry|January 20, 2006
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studiesJan Volavka, Pal Czobor, Leslie Citrome, et al.
Psychopharmacology|August 26, 2006
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medicationGwyneth Zai, Daniel J Müller, Jan Volavka, et al.
Human Psychopharmacology|August 19, 2007
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysisVincenzo De Luca, Daniel J Müller, Rudi Hwang, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch studyJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
Psychiatric Services (Washington, D.C.)|July 10, 2003
Characteristics of assaultive behavior among psychiatric inpatientsKaren A Nolan, Pál Czobor, Biman B Roy, et al.
The Journal of Clinical Psychiatry|January 28, 2004
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka, Pal Czobor, Thomas B Cooper, et al.
Journal of Psychiatric Research|October 27, 2004
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderKaren A Nolan, Jan Volavka, Pal Czobor, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
Antipsychotic-induced weight gain and therapeutic response: a differential associationPál Czobor, Jan Volavka, Brian Sheitman, et al.
Pageof 10